Moderna Inc
NASDAQ:MRNA

Watchlist Manager
Moderna Inc Logo
Moderna Inc
NASDAQ:MRNA
Watchlist
Price: 25.13 USD 1.66% Market Closed
Market Cap: 9.7B USD

Intrinsic Value

MRNA's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one MRNA stock under the Base Case scenario is 33.51 USD. Compared to the current market price of 25.13 USD, Moderna Inc is Undervalued by 25%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MRNA Intrinsic Value
33.51 USD
Undervaluation 25%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Moderna Inc

MRNA
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for MRNA cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Moderna’s revenue remains heavily reliant on its COVID-19 vaccine, and diminished global demand for boosters, along with heightened competition from alternative formulations, could significantly erode sales and margins.

Bull Theses

The mRNA platform’s modular nature and rapid development cycle positions Moderna to quickly expand its pipeline beyond COVID-19, enabling potential breakthroughs in vaccines for influenza, RSV, cancer, and rare diseases.

Show More Less
How do you feel about MRNA?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Moderna Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Moderna Inc

Current Assets 8.1B
Cash & Short-Term Investments 7B
Receivables 592m
Other Current Assets 482m
Non-Current Assets 6B
Long-Term Investments 2.5B
PP&E 3B
Intangibles 92m
Other Non-Current Assets 488m
Efficiency

Free Cash Flow Analysis
Moderna Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Moderna Inc

Revenue
3.2B USD
Cost of Revenue
-969m USD
Gross Profit
2.3B USD
Operating Expenses
-5.7B USD
Operating Income
-3.5B USD
Other Expenses
-111m USD
Net Income
-3.6B USD
Fundamental Scores

MRNA Profitability Score
Profitability Due Diligence

Moderna Inc's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Year Average ROE
Exceptional 3-Year Average ROIC
Positive Revenue Growth Forecast
34/100
Profitability
Score

Moderna Inc's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

MRNA Solvency Score
Solvency Due Diligence

Moderna Inc's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Negative Net Debt
Low D/E
Short-Term Solvency
68/100
Solvency
Score

Moderna Inc's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MRNA Price Targets Summary
Moderna Inc

Wall Street analysts forecast MRNA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MRNA is 53.14 USD with a low forecast of 25.25 USD and a high forecast of 222.6 USD.

Lowest
Price Target
25.25 USD
0% Upside
Average
Price Target
53.14 USD
111% Upside
Highest
Price Target
222.6 USD
786% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Moderna Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for MRNA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

MRNA Insider Trading
Buy and sell transactions by insiders

MRNA News

Other Videos
What is the Intrinsic Value of one MRNA stock?

The intrinsic value of one MRNA stock under the Base Case scenario is 33.51 USD.

Is MRNA stock undervalued or overvalued?

Compared to the current market price of 25.13 USD, Moderna Inc is Undervalued by 25%.

Back to Top